To further understand the sequential events induced by ConA-stimulated hepatoma cells, we used Stattic (STAT3 activation inhibitor) and found that it suppressed STAT3 phosphorylation, BNIP3 induction and LC3-II conversion (Figure 6d). The gene discussed is STAT3; the disease is hepatocellular carcinoma.